MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Is safinamide useful for atypical Parkinsonian syndromes?

    M. Machío Castelló, M. Oses Lara, C. Feliz Feliz, J. del Val, P. García Ruiz (Madrid, Spain)

    Objective: Seeking new treatment strategies in atypical Parkinsonian syndromes Background: Atypical parkinsonian syndromes (APS) include several entities leading to parkinsonism with atypical features such as…
  • 2018 International Congress

    Deep brain stimulation in a patient with Spinocerebellar ataxia type 2 presenting as Parkinson’s disease: A case report

    J. Im, Y. Lee, S. Paek, B. Jeon (Seoul, Republic of Korea)

    Objective: The role of subthalamic nucleus - deep brain stimulation (STN-DBS) is well established in medically refractory Parkinson's disease. But the efficacy of DBS surgery…
  • 2018 International Congress

    Using remotely collected data to identify Parkinson’s disease (PD) subtypes

    T. Dominey, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the possibility of using remotely collected data to allocate newly diagnosed PD patients to phenotypic subgroups, to identify patients suitable for inclusion…
  • 2018 International Congress

    Using saccades as an early test of levodopa treatment in Parkinson’s Disease

    Z.J. Lu, S. Dillon, P. Zetegren, M. Brzezick, C. Kennard, J. FitzGerald, C. (Oxford, United Kingdom)

    Objective: It is important to know what potential confounding effects the medications used to treat Parkinson’s disease (PD) have on eye movement, in order to…
  • 2018 International Congress

    The Predictor Factors on Quality of Life in Patients with Parkinson’s Disease

    AD. Wijono, RT. Pinzon (Yogyakarta, Indonesia)

    Objective: This study was designed to explore the impact of various predictive factors on the quality of life (QOL) of patients with Parkinson's disease (PD).…
  • 2018 International Congress

    Motor Performance and Quality of Life in a Community Exercise Program for Parkinson’s Disease

    E. Stiles, K. Jaffe, B. Rossi, D. Riley (University Heights, OH, USA)

    Objective: To present 1-year results of motor and QoL assessments of participants in physical activity programs at the InMotion (IM) community center. Background: Numerous studies…
  • 2018 International Congress

    Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

    S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)

    Objective: To study the efficacy of incobotulinumtoxin A (IncoA) in relieving the symptoms of restless legs syndrome (RLS) Background: RLS is a common movement disorder…
  • 2018 International Congress

    Smartphone App-Based Assessment of Gait in patients with Parkinson’s disease

    D. Su, Z. Liu, W. Yu, H. Zhu, O. Lo, B. Manor, T. Feng, J. Zhou (Beijing, China)

    Objective: The purpose of this pilot study was to determine if gait metrics derived from the App correlated with clinical symptoms and functional performance in…
  • 2018 International Congress

    Feasibility of a multi-sensor data fusion method for assessment of Parkinson’s disease motor symptoms

    M. Memedi, S. Aghanavesi, D. Nyholm, F. Bergquist, M. Senek (Örebro, Sweden)

    Objective: To assess the feasibility of measuring Parkinson’s disease (PD) motor symptoms with a multi-sensor data fusion method. More specifically, the aim is to assess…
  • 2018 International Congress

    Personal KinetiGraph™ Movement Recording System: An Assessment of Utility in a Movement Disorder Clinic

    F. Nahab, H. Abuhussain, L. Moreno (La Jolla, CA, USA)

    Objective: The objective of this open-label study was to evaluate the clinical utility of the Personal KinetiGraph™ (PKG) Movement Recording System in the care of…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley